Who are 6-tioguanine+Standard Maintenance Therapy's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Folfox-7, Folfiri, Different Antibiotic Combinations, mFOLFOX6 or CAPOX, Azathioprine (AZA), Fludarabine (Bayer).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/6-tioguanine-standard-maintenance-therapy.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

6-tioguanine+Standard Maintenance Therapy — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

6-tioguanine+Standard Maintenance Therapy (6-tioguanine-standard-maintenance-therapy) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: purine analog. Area: Oncology.

marketed purine analog DNA replication Oncology Live · refreshed every 30 min

Target snapshot

6-tioguanine+Standard Maintenance Therapy (6-tioguanine-standard-maintenance-therapy) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
6-tioguanine+Standard Maintenance Therapy TARGET	6-tioguanine-standard-maintenance-therapy	Pfizer	marketed	purine analog	DNA replication
Folfox-7	folfox-7	Pfizer	marketed	chemotherapy	DNA replication machinery
Folfiri	folfiri	Pfizer	marketed	chemotherapy	DNA replication and repair
Different Antibiotic Combinations	Different Antibiotic Combinations	Inonu University	marketed	Antibiotic combinations	Multiple bacterial targets including cell wall synthesis, protein synthesis, and DNA replication
mFOLFOX6 or CAPOX	mFOLFOX6 or CAPOX	LI XIN-XIANG	phase 3	Platinum-based chemotherapy	DNA replication machinery
Azathioprine (AZA)	Azathioprine (AZA)	University Hospital Schleswig-Holstein	marketed	Purine analog immunosuppressant	Inosine monophosphate dehydrogenase (IMPDH), purine synthesis pathway
Fludarabine (Bayer)	Fludarabine (Bayer)	Chinese PLA General Hospital	marketed	Purine analog antimetabolite	Ribonucleotide reductase, DNA polymerase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (purine analog class)

Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 6-tioguanine+Standard Maintenance Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/6-tioguanine-standard-maintenance-therapy. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab